AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2014
Jul 10, 2014
35086_dirs_2014-07-09_29c61a71-a2aa-46e4-bc94-a035dcd96798.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2014-06-30
Reporting Person: Vivaldi Coelho Rogerio (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-01 | Common Stock | P | 41667 | $6.00 | Acquired | 41667 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | Employee Stock Option (right to buy) | $6.00 | A | 498621 | Acquired | 2024-06-29 | Common Stock (498621) | Direct |
Footnotes
F1: 25% of the shares subject to the option will become exercisable on November 1, 2014 and the balance of the shares will become exercisable in a series of twelve equal quarterly installments upon Dr. Vivaldi's completion of each quarter of service over the three year period thereafter.
More from Minerva Neurosciences, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17